JACOBIO-B: FORM OF PROXY FOR THE 2024 ANNUAL GENERAL MEETING
Apr 26 05:08 ET
JACOBIO-B: NOTICE OF 2024 ANNUAL GENERAL MEETING
Apr 26 05:06 ET
JACOBIO-B: PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, PROPOSED RE-ELECTION OF DIRECTORS, PROPOSED CHANGE OF AUDITOR AND NOTICE OF ANNUAL GENERAL MEETING
Apr 26 05:05 ET
JACOBIO-B: PROPOSED CHANGE OF AUDITOR
Apr 24 10:27 ET
JACOBIO-B: 2023 ANNUAL REPORT
Apr 24 08:48 ET
JACOBIO-B: VOLUNTARY ANNOUNCEMENT JACOBIO PRESENT ED CLINICAL DATA OF PARP7 INHIBITOR JAB-26766 AND P53 REACTIVATOR JAB-30355 AT THE AACR 2024
Apr 9 07:26 ET
JACOBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2024
Apr 3 04:58 ET
JACOBIO-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023
Mar 28 10:26 ET
JACOBIO-B: DATE OF BOARD MEETING
Mar 18 04:38 ET
JACOBIO-B: VOLUNTARY ANNOUNCEMENT
Mar 5 05:27 ET
JACOBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 29 February 2024
Mar 4 03:40 ET
JACOBIO-B: Notification Letter and Reply Form to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
Mar 1 03:05 ET
JACOBIO-B: Notification Letter and Reply Form to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
Mar 1 02:59 ET
JACOBIO-B: VOLUNTARY ANNOUNCEMENT JACOBIO RECEIVED US FDA INVESTIGATIONAL NEW DRUG CLEARANCE FOR P53 Y220C Activator JAB-30300
Feb 29 23:09 ET
JACOBIO-B: VOLUNTARY ANNOUNCEMENT THE REGISTRATIONAL PHASE III CLINICAL TRIAL OF SHP2 INHIBITOR JAB-3312 IN COMBINATION WITH KRAS G12C INHIBITOR GLECIRASIB APPROVED BY THE CENTER FOR DRUG EVALUATION (CDE) OF THE NMPA
Feb 18 06:50 ET
JACOBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 January 2024
Feb 5 03:42 ET
JACOBIO-B: VOLUNTARY ANNOUNCEMENT JACOBIO PRESENTED CLINICAL DATA OF KRAS G12C INHIBITOR GLECIRASIB IN PATIENTS WITH PANCREATIC CANCER AND OTHER SOLID TUMORS AT THE 2024 ASCO GI
Jan 21 05:08 ET
JACOBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 December 2023
Jan 4 03:47 ET
JACOBIO-B: NEXT DAY DISCLOSURE RETURN
Dec 22, 2023 03:38 ET
JACOBIO-B: VOLUNTARY ANNOUNCEMENT JACOBIO TO PRESENT CLINICAL DATA OF KRAS G12C INHIBITOR GLECIRASIB IN PATIENTS WITH PANCREATIC CANCER AND OTHER SOLID TUMORS AT THE 2024 ASCO GI
Dec 6, 2023 23:00 ET
No Data
No Data